chr14-81143715-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PS1_ModeratePM1PP3_ModeratePP5
The NM_000369.5(TSHR):c.1657G>A(p.Ala553Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000589 in 1,613,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_000369.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSHR | NM_000369.5 | c.1657G>A | p.Ala553Thr | missense_variant | 10/10 | ENST00000298171.7 | NP_000360.2 | |
LOC101928462 | XR_001751022.2 | n.487+21478C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSHR | ENST00000298171.7 | c.1657G>A | p.Ala553Thr | missense_variant | 10/10 | 1 | NM_000369.5 | ENSP00000298171 | P1 | |
ENST00000646052.2 | n.510+21478C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251360Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135842
GnomAD4 exome AF: 0.0000622 AC: 91AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 727238
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152022Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74236
ClinVar
Submissions by phenotype
Hypothyroidism due to TSH receptor mutations Pathogenic:4
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 1997 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 16, 2024 | Variant summary: TSHR c.1657G>A (p.Ala553Thr) results in a non-conservative amino acid change located in the GPCR, rhodopsin-like, 7TM domain (IPR017452) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 251360 control chromosomes. c.1657G>A has been reported in the literature in multiple biallelic individuals affected with Hypothyroidism Due To TSH Receptor Mutations (e.g. Abramowicz_1997, Cangul_2010). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in reduced TSH-induced cyclic adenosine monophosphate (cAMP) signaling in COS-7 cells (Abramowicz_1997). The following publications have been ascertained in the context of this evaluation (PMID: 9185526, 20718767). ClinVar contains an entry for this variant (Variation ID: 6445). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The TSHR c.1657G>A (p.Ala553Thr) missense variant is described in five studies in which it is identified in seven patients with congenital hyopthyroidism including in a homozygous state in two pairs of consanguineous siblings and in a compound heterozygous state in two non-consanguineous siblings and an additional unrelated patient (Abramowicz et al. 1997; Park et al. 2004; Cangul et al. 2010; Cangul et al. 2012; van Tellingen et al. 2016). The variant was absent from 400 control alleles but is reported at a frequency of 0.00003 in the total population of the Exome Aggregation Consortium. Functional studies in COS-7 cells demonstrated that the p.Ala553Thr variant resulted in extremely low cell-surface expression of the receptor compared to wild type (Abramowicz et al. 1997). The Ala553 residue is highly conserved (Abramowicz et al. 1997; Cangul et al. 2010). Stability studies showed that the variant was expected to be significantly destabilizing for the protein (Cangul et al. 2010). Based on the collective evidence, the p.Ala553Thr variant is classified as likely pathogenic for congenital hypothyroidism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 07, 2016 | - - |
Familial gestational hyperthyroidism Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 23, 2024 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2021 | The c.1657G>A (p.A553T) alteration is located in exon 10 (coding exon 10) of the TSHR gene. This alteration results from a G to A substitution at nucleotide position 1657, causing the alanine (A) at amino acid position 553 to be replaced by a threonine (T). Based on the available evidence, this variant is expected to be causative of congenital nongoitrous hypothyroidism (AR) when present along with a second pathogenic or likely pathogenic variant on the other allele; however, it is unlikely to be causative of nonautoimmune hyperthyroidism (AD). Based on data from gnomAD, the A allele has an overall frequency of <0.01% (8/251360) total alleles studied. The highest observed frequency was 0.01% (2/30616) of South Asian alleles. This alteration has been detected in the homozygous state or compound heterozygous with a second TSHR variant in multiple unrelated individuals with congenital hypothyroidism (Abramowicz, 1997; Park, 2004; Cangul, 2010; van Tellingen, 2016). Heterozygous carriers of this variant have been reported with subclinical or mild hypothyroidism (Nicoletti, 2009; Abe, 2018). This amino acid position is highly conserved in available vertebrate species. The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as pathogenic. - |
TSHR-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 02, 2024 | The TSHR c.1657G>A variant is predicted to result in the amino acid substitution p.Ala553Thr. This variant has been reported in the monoallelic or bi-allelic state in individuals with Hypothyroidism (Abramowicz et al. 1997. PubMed ID: 9185526; Park et al. 2004. PubMed ID: 14725684; Abe et al. 2017. PubMed ID: 29092890). This variant is reported in 0.0065% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 553 of the TSHR protein (p.Ala553Thr). This variant is present in population databases (rs121908872, gnomAD 0.006%). This missense change has been observed in individual(s) with hypothyroidism (PMID: 9185526, 14725684, 20718767, 27255745, 29092890). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6445). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TSHR protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects TSHR function (PMID: 9185526, 10560953). For these reasons, this variant has been classified as Pathogenic. - |
Familial hyperthyroidism due to mutations in TSH receptor Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at